In contrast to ITP, transient thrombocytopenia in CTP is resistant to ITP treatment options such as corticosteroid, immunoglobulin, splenectomy, immunosuppressive, or thrombopoietin receptor agonists [9]. The gene discussed is MPL; the disease is autoimmune thrombocytopenic purpura.